Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 2Phase 1/2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 637Head & Neck 94Breast 40Genitourinary 17Gynecologic 16Tumor-Agnostic 13Thoracic 7Dermatologic 7Other solid neoplasm 5Endocrine 4Sarcoma 2Other neoplasm 1Other 1Lymphoid 1

Conditions

Sarcoma 2Head and Neck Neoplasms 2Carcinoma 2

Interventions

Cyclophosphamide 93Doxorubicin 92Radiotherapy 87Temozolomide 69Filgrastim 58Ifosfamide 55Bevacizumab 55Etoposide 48Gemcitabine 44Imatinib Mesylate 43Vincristine 40pembrolizumab 35pazopanib 34Peripheral Blood Stem Cell Transplantation 31Methotrexate 31Nivolumab 30Carboplatin 30fludarabine phosphate 29Irinotecan 29Cisplatin 28Paclitaxel 26Melphalan 26Magnetic Resonance Spectroscopy 26Docetaxel 25Busulfan 25Trabectedin 24apatinib 22Specimen Handling 21Sirolimus 21Antilymphocyte Serum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Fluorouracil × Sarcoma × Clear all
NCT01063075 2019-09-26

A Study in Advanced Solid Tumors

Eli Lilly and Company

Phase 2 Completed
34 enrolled 15 charts
Head & NeckSarcoma

Carcinoma, Head and Neck Neoplasms, Sarcoma

NCT01099358 2019-09-26

Study in Advanced Solid Tumors

Eli Lilly and Company

Phase 2 Completed
47 enrolled 15 charts
Head & NeckSarcoma

Carcinoma, Head and Neck Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡